Investigating a strategy for quantifying schistosome infection levels in preschool-aged children using prevalence data from school-aged children

In 2012, the World Health Organisation (WHO) set out a roadmap for eliminating schistosomiasis as a public health problem by 2025. To achieve this target, preschool-aged children (PSAC; aged 6 years and below) will need to be included in schistosomiasis treatment programmes. As the global community...

Full description

Bibliographic Details
Main Authors: Rivka M. Lim, Mark E. J. Woolhouse, Takafira Mduluza, Margo Chase-Topping, Derick N. M. Osakunor, Lester Chitsulo, Francisca Mutapi, Uwem Friday Ekpo
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-10-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529243/?tool=EBI
id doaj-94b53c1b753b411ea7e5d8386d92087f
record_format Article
spelling doaj-94b53c1b753b411ea7e5d8386d92087f2020-11-25T03:44:13ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352020-10-011410Investigating a strategy for quantifying schistosome infection levels in preschool-aged children using prevalence data from school-aged childrenRivka M. LimMark E. J. WoolhouseTakafira MduluzaMargo Chase-ToppingDerick N. M. OsakunorLester ChitsuloFrancisca MutapiUwem Friday EkpoIn 2012, the World Health Organisation (WHO) set out a roadmap for eliminating schistosomiasis as a public health problem by 2025. To achieve this target, preschool-aged children (PSAC; aged 6 years and below) will need to be included in schistosomiasis treatment programmes. As the global community discusses the tools and approaches for treating this group, one of the main questions that remains unanswered is how to quantify infection in this age group to inform treatment strategies. The aim of this study was thus to determine whether a relationship exists between levels of schistosome infection in PSAC and school-aged children (SAC), that can be used to determine unknown schistosome infection prevalence levels in PSAC. A systematic search of publications reporting schistosomiasis prevalence in African PSAC and SAC was conducted. The search strategy was formulated using the PRISMA guidelines and SPIDER search strategy tool. The published data was subjected to regression analysis to determine if a relationship exists between infection levels in PSAC and SAC. The interaction between SAC and community treatment history was also entered in the regression model to determine if treatment history significantly affected the relationship between PSAC and SAC prevalence. The results showed that a significant positive relationship exists between infection prevalence levels in PSAC and SAC for Schistosoma mansoni (r = 0.812, df (88, 1), p = <0.0001) and S. haematobium (r = 0.786, df (53, 1), p = <0.0001). The relationship was still significant after allowing for diagnostic method, treatment history, and the African sub-region where the study was conducted (S. mansoni: F = 25.63, df (88, 9), p = <0.0001; S. haematobium: F = 10.20, df (53, 10), p = <0.0001). Using the regression equation for PSAC and SAC prevalence, over 90% of the PSAC prevalence studies were placed in the correct WHO classifications category based on the SAC levels, regardless of treatment history. The study indicated that schistosome prevalence in SAC can be extended as a proxy for infection levels in PSAC, extending on its current use in the adult population. SAC prevalence data could identify where there is a need to accelerate and facilitate the treatment of PSAC for schistosomiasis in Africa. Author summary Preschool-aged children (PSAC), i.e. aged ≤ 6 years, are not included in preventative chemotherapy programmes, currently advocated by the WHO for the treatment of schistosomiasis. This is due to the lack of a paediatric formulation of the drug of choice, praziquantel, and the current guidelines which requires diagnosis before treatment. As the global community prepares for the deployment of a new paediatric formulation of praziquantel, there is a need to find a strategy to quantify infection in this age group. In schistosome endemic areas, infection levels in school-aged children (SAC) are already used to inform infection levels in the community. Thus, we investigated the relationship between SAC and PSAC schistosome prevalence levels within the same community, to determine if data from SAC could be used to predict infection levels in PSAC. Our results show that PSAC prevalence levels are significantly correlated with SAC prevalence levels. Our findings are applicable to communities that have received preventative chemotherapy in SAC or in SAC and adults, as well as those that have not received any. Our study indicates that it is possible to extrapolate PSAC prevalence levels from SAC prevalence, and to make a treatment decision on that basis.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529243/?tool=EBI
collection DOAJ
language English
format Article
sources DOAJ
author Rivka M. Lim
Mark E. J. Woolhouse
Takafira Mduluza
Margo Chase-Topping
Derick N. M. Osakunor
Lester Chitsulo
Francisca Mutapi
Uwem Friday Ekpo
spellingShingle Rivka M. Lim
Mark E. J. Woolhouse
Takafira Mduluza
Margo Chase-Topping
Derick N. M. Osakunor
Lester Chitsulo
Francisca Mutapi
Uwem Friday Ekpo
Investigating a strategy for quantifying schistosome infection levels in preschool-aged children using prevalence data from school-aged children
PLoS Neglected Tropical Diseases
author_facet Rivka M. Lim
Mark E. J. Woolhouse
Takafira Mduluza
Margo Chase-Topping
Derick N. M. Osakunor
Lester Chitsulo
Francisca Mutapi
Uwem Friday Ekpo
author_sort Rivka M. Lim
title Investigating a strategy for quantifying schistosome infection levels in preschool-aged children using prevalence data from school-aged children
title_short Investigating a strategy for quantifying schistosome infection levels in preschool-aged children using prevalence data from school-aged children
title_full Investigating a strategy for quantifying schistosome infection levels in preschool-aged children using prevalence data from school-aged children
title_fullStr Investigating a strategy for quantifying schistosome infection levels in preschool-aged children using prevalence data from school-aged children
title_full_unstemmed Investigating a strategy for quantifying schistosome infection levels in preschool-aged children using prevalence data from school-aged children
title_sort investigating a strategy for quantifying schistosome infection levels in preschool-aged children using prevalence data from school-aged children
publisher Public Library of Science (PLoS)
series PLoS Neglected Tropical Diseases
issn 1935-2727
1935-2735
publishDate 2020-10-01
description In 2012, the World Health Organisation (WHO) set out a roadmap for eliminating schistosomiasis as a public health problem by 2025. To achieve this target, preschool-aged children (PSAC; aged 6 years and below) will need to be included in schistosomiasis treatment programmes. As the global community discusses the tools and approaches for treating this group, one of the main questions that remains unanswered is how to quantify infection in this age group to inform treatment strategies. The aim of this study was thus to determine whether a relationship exists between levels of schistosome infection in PSAC and school-aged children (SAC), that can be used to determine unknown schistosome infection prevalence levels in PSAC. A systematic search of publications reporting schistosomiasis prevalence in African PSAC and SAC was conducted. The search strategy was formulated using the PRISMA guidelines and SPIDER search strategy tool. The published data was subjected to regression analysis to determine if a relationship exists between infection levels in PSAC and SAC. The interaction between SAC and community treatment history was also entered in the regression model to determine if treatment history significantly affected the relationship between PSAC and SAC prevalence. The results showed that a significant positive relationship exists between infection prevalence levels in PSAC and SAC for Schistosoma mansoni (r = 0.812, df (88, 1), p = <0.0001) and S. haematobium (r = 0.786, df (53, 1), p = <0.0001). The relationship was still significant after allowing for diagnostic method, treatment history, and the African sub-region where the study was conducted (S. mansoni: F = 25.63, df (88, 9), p = <0.0001; S. haematobium: F = 10.20, df (53, 10), p = <0.0001). Using the regression equation for PSAC and SAC prevalence, over 90% of the PSAC prevalence studies were placed in the correct WHO classifications category based on the SAC levels, regardless of treatment history. The study indicated that schistosome prevalence in SAC can be extended as a proxy for infection levels in PSAC, extending on its current use in the adult population. SAC prevalence data could identify where there is a need to accelerate and facilitate the treatment of PSAC for schistosomiasis in Africa. Author summary Preschool-aged children (PSAC), i.e. aged ≤ 6 years, are not included in preventative chemotherapy programmes, currently advocated by the WHO for the treatment of schistosomiasis. This is due to the lack of a paediatric formulation of the drug of choice, praziquantel, and the current guidelines which requires diagnosis before treatment. As the global community prepares for the deployment of a new paediatric formulation of praziquantel, there is a need to find a strategy to quantify infection in this age group. In schistosome endemic areas, infection levels in school-aged children (SAC) are already used to inform infection levels in the community. Thus, we investigated the relationship between SAC and PSAC schistosome prevalence levels within the same community, to determine if data from SAC could be used to predict infection levels in PSAC. Our results show that PSAC prevalence levels are significantly correlated with SAC prevalence levels. Our findings are applicable to communities that have received preventative chemotherapy in SAC or in SAC and adults, as well as those that have not received any. Our study indicates that it is possible to extrapolate PSAC prevalence levels from SAC prevalence, and to make a treatment decision on that basis.
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529243/?tool=EBI
work_keys_str_mv AT rivkamlim investigatingastrategyforquantifyingschistosomeinfectionlevelsinpreschoolagedchildrenusingprevalencedatafromschoolagedchildren
AT markejwoolhouse investigatingastrategyforquantifyingschistosomeinfectionlevelsinpreschoolagedchildrenusingprevalencedatafromschoolagedchildren
AT takafiramduluza investigatingastrategyforquantifyingschistosomeinfectionlevelsinpreschoolagedchildrenusingprevalencedatafromschoolagedchildren
AT margochasetopping investigatingastrategyforquantifyingschistosomeinfectionlevelsinpreschoolagedchildrenusingprevalencedatafromschoolagedchildren
AT dericknmosakunor investigatingastrategyforquantifyingschistosomeinfectionlevelsinpreschoolagedchildrenusingprevalencedatafromschoolagedchildren
AT lesterchitsulo investigatingastrategyforquantifyingschistosomeinfectionlevelsinpreschoolagedchildrenusingprevalencedatafromschoolagedchildren
AT franciscamutapi investigatingastrategyforquantifyingschistosomeinfectionlevelsinpreschoolagedchildrenusingprevalencedatafromschoolagedchildren
AT uwemfridayekpo investigatingastrategyforquantifyingschistosomeinfectionlevelsinpreschoolagedchildrenusingprevalencedatafromschoolagedchildren
_version_ 1724515479737860096